Vivolight

Vivolight has established itself as a pioneer in medical laser technology since its founding in 2012. Jointly created by the Xi’an Institute of Optics and Precision Mechanics of the Chinese Academy of Sciences and venture capital partners from Shenzhen and Xi’an, the company operates from its Shenzhen headquarters with an R&D center in Xi’an.

Company Overview

The company’s research team originated from Tsinghua University’s OCT Imaging Laboratory, representing China’s first dedicated optical coherence tomography research group. This academic foundation enabled Vivolight to develop China’s first frequency-domain 3D-OCT for ophthalmic diagnosis in 2008 and the world’s first handheld OCT device for ophthalmic surgery in 2010.

Vivolight has accumulated over 140 patents across its technology portfolio, achieving complete domestic production of all core components. The company maintains partnerships with Tsinghua University, Harbin Institute of Technology, and The University of Hong Kong, operating joint engineering centers with the Chinese Academy of Sciences.

Core Products

Intravascular OCT Imaging Systems

The multimodal cardiovascular OCT system represents Vivolight’s flagship product. In April 2025, this system received FDA 510(k) clearance, becoming the first multimodal cardiovascular OCT system worldwide and the first intravascular imaging device from China to obtain FDA approval.

The system integrates three diagnostic modalities in a single catheter pull:

• High-definition OCT for vessel structure imaging
• Index of Plaque Attenuation (IPA) for plaque stability assessment
• OCT-derived FFR for functional evaluation with 96.05% correlation to wire-based FFR

Projection Vein Finder Series

The V800 series vein finders use near-infrared light technology to project real-time vein images onto the skin surface. These devices assist healthcare professionals in locating peripheral veins for IV insertion, blood draws, and other venipuncture procedures.

Key products include the V800P portable unit and V800F fixed-mount system, both designed for high-frequency clinical use with non-contact, radiation-free operation.

VGlasses AR Vein Finder

Described as the world’s first digital vascular visualization product combining augmented reality with infrared technology, VGlasses provides wearable hands-free vein visualization. The device overlays vein patterns onto the user’s field of view while maintaining visibility of the real clinical environment.

Technology & Innovation

Vivolight’s technology platform encompasses three core domains: laser diagnostics, fiber-optic catheter systems, and image processing algorithms. The company achieved complete localization of core components, including robotic automated production of key modules.

For OCT systems, Vivolight developed proprietary algorithms for automatic calcium scoring (ICA) featuring the world’s first 3D calcium assessment. The integration of morphological, histological, and functional diagnostics in a single device reduces procedure time and consumable costs.

Market Presence

In China’s OCT market, Vivolight is one of the leading domestic providers alongside Abbott and other foreign incumbents per company reporting; Vivolight has reported triple-digit annual sales growth over recent years. The company became the first Chinese OCT manufacturer to enter international markets in 2023.

Vein finder products have been adopted across Southeast Asia, Latin America, and other regions, with applications spanning pediatric wards, oncology departments, aesthetic medicine centers, and emergency services.

Key Milestones

• 2008: Developed China’s first frequency-domain 3D-OCT for ophthalmology
• 2010: Created world’s first handheld OCT for ophthalmic surgery
• 2012: Company founded in Shenzhen
• 2022: Completed Series D1 financing exceeding 100 million RMB
• 2023: First Chinese OCT manufacturer to enter overseas markets
• 2024: Completed strategic financing round exceeding 100 million RMB
• 2025: Multimodal cardiovascular OCT system received FDA clearance

Frequently Asked Questions

What products does Vivolight manufacture?

Vivolight produces two main product categories: intravascular OCT imaging systems for cardiovascular intervention procedures, and peripheral vein visualization devices including projection vein finders and AR-enabled vein viewing glasses.

Has Vivolight received FDA approval?

Yes. In April 2025, Vivolight’s multimodal cardiovascular OCT system and associated catheter received FDA 510(k) clearance, making it the first such device from a Chinese manufacturer to obtain FDA approval.

Where can Vivolight vein finders be purchased?

Vivolight distributes products through regional partners across Asia, Latin America, Europe, and the Middle East. Contact the company directly through their website for distributor information in specific regions.